In consistent with the findings of Parmiani et al, we demonstrated that a high intratumoral GM-CSF expression was an independent predictor of diminished RFS for clinically localized ccRCC patients. The gene discussed is CSF2; the disease is nonpapillary renal cell carcinoma.